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Bacterial cells have developed two basic types of active transport systems. 
One of these transport systems is a membrane-bound system and can be ob- 
served in membrane vesicle preparations prepared by the methods described 
in the previous presentation by Kaback.' Dr. Kaback described the transport 
properties of membrane vesicles from gram-negative bacteria that retain the 
membrane-bound transport system. He has shown that these membranes retain 
all components of the transport system except an energy source, which is 
necessary for the system to produce active transport. The membrane-bound 
systems derive their energy from an "energy-rich membrane state," which 
can be formed in a variety of ways such as respiration, ATP hydrolysis, 
or proton gradient-forming conditions." ' 
A second type of active transport system that I would like to describe 
is a system that requires a shockable binding protein to produce active trans- 
port."'-'' It appears that the binding protein transport systems obtain their 
cellular energy more directly from phosphate bound energy derived from 
glycolysis or oxidative phosphorylation.' These low molecular weight binding 
proteins can be removed from the bacterial cells by a cold osmotic shock 
treatment. In general osmotic shock treatment selectively destroys the type-two 
transport systems for which binding proteins can be isolated and has little 
effect on type-one transport systems in which the receptor site is tightly bound 
to the membrane. 
The membrane of E. coli is a complicated triple-layer structure and the 
binding proteins appear to occupy the space between the outer and inner 
membranes of the cell envelope. The mild treatment of cold osmotic shock 
was worked out by Neu and HeppeLS The procedure is illustrated in FIGURE 
1. In the first step cells are harvested in middle or late log phase and washed 
several times with Tris-HCI, pH 7. The washed cells are suspended in 40 
to 80 volumes of room temperature 20% sucrose solution containing 0.1 
mM EDTA. The cell suspension is stirred gently for 10 minutes and then 
centrifuged. The pellet is rapidly resuspended in 40 to 80 volumes of ice-cold 
distilled water containing 0.1 mM MgCL. The suspension is stirred for 10 
minutes and centrifuged. The supernatant fluid is called the "shock fluid" 
and contains a number of hydrolytic enzymes as well as the binding proteins 
for various solutes. Usually about 4% of the total cellular protein is lost 
from the cells during this treatment. The procedure must be modified for 
certain strains that are more sensitive to osmotic shock treatment such as 
Pseudomonas species. 
When we treated E. coli K12 by the osmotic shock treatment we found 
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FIGURE 2. Elution profile of the .a 
DEAE-cellulose fractionation of the ,+ 
osmotic material is hock indicated fluid. by Crossreactive bar . (From
Rahmanian et a1." By permission of 
the Journal of Bacteriology.) 
.6: 




FIGURE 1. Schematic diagram of the process of osmotic shock and its effect on 
the bacterial cell. 
that the transport activity for the branched-chain amino acids was greatly 
decreased. We examined the shock fluid and discovered leucine-binding activity 
by equilibrium dialysis.a* ' 
Following concentration by ultrafiltration, the shock fluid was prepared 
for DEAE-cellulose by desalting on a Biogel-P10 column. The protein solution 
is applied to a DEAE-cellulose column equilibrated with 5 mM Tris-HCI, 
pH 7.6. The column was eluted with a linear gradient of sodium chloride. 
Three peaks with binding activity for branched-chain amino acids were found, 
corresponding to the LIV-binding protein, an isoleucine-preferring protein, 
and the leucine-specific protein.', la The elution pattern is illustrated in FIGURE 
2. All three binding proteins crossreact with antibody prepared from the LIV-I 
binding protein, suggesting a considerable structural similarity. The bars in 
FIGURE 2 indicate crossreaction with anti-LIV-I antibody. The leucine-specific 
protein is purified to homogeneity by preparative polyacrylamide gel electro- 
phoresis and crystallized from ammonium sulfate.' The isoleucine-preferring 
protein has not been extensively studied. The LIV-binding protein fraction 
from the DEAE-cellulose is purified with two steps, hydroxylapatite chromato- 
graphy and isoelectric focusing. A final purification step can be achieved by 
I 
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crystallization from 50-55 % a-methyl-2,4-pentanediol.' Two crystal forms exist 
that depend on the pH at which crystallization takes place. At neutral pH 
values, needle-like crystals have been obtained,' while at pH 4 hexagonal col- 
umns occur (FIGURE 3). Initial x-ray diffraction studies have shown good 
resolution and suggest the possibility of doing structural studies by this tech- 
nique. A large number of other binding proteins for amino acids, ions, sugars, 
and vitamins have been isolated by similar techniques from bacteria. TABLE 
1 lists some of these binding proteins and some physical properties that have 
been measured. References for the purification technique have also been 
included. 
As indicated in this Table, the leucine-specific binding protein has a molecu- 
lar weight of 37,000,N very similar to that obtained for the LIV-binding protein.' 
The LIV-binding protein is very stable to various denaturation procedures. 
The active binding form is the thermodynamically favored conformation, and 
denaturation by heat treatment, urea, or guanidine-HC1 is fully reversible. 
This is a general feature of the periplasmic binding proteins. The Kd for 
leucine is about M for both the branched-chain amino acid binding pro- 
teins. The similarity of the two proteins is confirmed by the crossreactivity 
either protein exhibits when antibodies are prepared to leucine-specific or 
LIV-protein alone. Crossreactivity is also shown between the arabinose- and 
the galactose-binding proteins of E. coli B/r.'* 
Specific antibodies have been used to localize the binding proteins to the 
cell envelope.", In the study of Nakane et al.," antibodies to the LIV-protein 
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were used in an enzyme-labeled technique. Late log phase cells were fixed 
in acetone, washed with phosphate buffer, and treated with rabbit antibody 
to the binding protein. The cells were then washed and allowed to react 
with sheep anti-rabbit globulin that had been conjugated to horseradish peroxi- 
dase. The fixed cells were stained cytochemically for peroxidase. The location 
of the insoluble product, which reacts with osmium tetraoxide, could be ob- 
served in the electron microscope. Using unimmunized rabbit serum as control, 
it was possible to localize the reaction to the cell wall or cell membrane. 
Using the fluorescent reagent, diazo-7-amino-l,3-naphthalene disulfonate, 
Pardee and Watanabe" obtained evidence that the sulfate-binding protein was 
located internal to the cell wall, but external to the plasma membrane. This 
reagent penetrates the cell wall but not the cellular membrane. 
Multiplicity of Branched-Chain Amino Acid Systems 
When the kinetics of leucine transport were examined over a wide concen- 
tration range the reciprocal plots of the initial rates of uptake were distinctly 
biphasic, indicating heterogeneity in leucine transport." The multiplicity of 
branched-chain amino acid systems has been confirmed in other labora- 
tories.% 18-15. We have used a combination of kinetic, genetic, and biochemical 
studies to describe the number of transport systems that serve for leucine, 
isoleucine, and valine. 
High-Afinity Uptake Systems 
The high-affinity component of the kinetic plot is composed of at least 
three transport systems. The major high-affinity system is called the LIV-I 
system. This system has a broad specificity since it serves for leucine, isoleucine, 
valine, threonine, alanine, homoserine,lG cysteine, serine, methionine, and a 
variety of analogs."* Additional minor high-affinity systems are represented 
by a leucine-specific system (L-S system) ** " and an isoleucine-preferring system 
(I-system) .Iu These three systems each have approximately the same Km value 
for uptake of their preferred substrate (0.2 pM). Thus, they appear collectively 
as one component in the kinetic plots of uptake of the respective substrate. 
All three of these systems are repressible by leucine in the growth media 
and are sensitive to osmotic shock treatment. The three proteins (isolated 
as described and shown in FIGURE 2) have specificities that correspond to 
the three high-affinity transport systems described above. In wild type E. coli 
the LIV-I system constitutes about 75 to 85% of the high-affinity uptake 
of leucine and isoleucine, while the specific uptake systems constitute the 
balance of the high-affinity transport of these amino acids. 
Low-Afinity Transport of Leucine, Zsoleucine, and Valine 
The low-affinity component of the kinetic plot of leucine uptake is referred 
to as the LIV-I1 transport system. This component is not sensitive to osmotic 
shock treatment and can be observed in shocked cells. It is not subject to 
repression by growth of the cells on leucine. Kinetic plots of leucine uptake 
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in shocked cells or cells grown in the presence of leucine are essentially linear 
and provide a good measure of the LIV-I1 transport component. The Km 
values for leucine and isoleucine are from 2 to 4 micr~molar.’~ The Km 
value for valine is around 10 to 20 micromolar. 
In contrast to the LIV-I system, the LIV-I1 transport system is much 
more specific for leucine, isoleucine, and valine. Some analogs of the branched- 
chain amino acids such as norleucine“ have low affinity for the LIV-I1 system. 
Since the LIV-I1 system is not sensitive to osmotic shock treatment, it can 
also be observed in membrane vesicle preparations of bacteria as described 
in the previous presentation by Kaback. In wild-type E. coli K12 the LIV-I1 
system ordinarily constitutes about 10 to 15% of the uptake of 1 x 
M leucine. At this concentration of leucine both high- and low-affinity transport 
systems would be saturated. 
Regulation of Leucine Transport 
We have previously shown that when cells are grown in nutrient medium 
or in media containing leucine the transport activity and binding activity is 
repressed.‘ The represson by leucine of both transport and shockable-binding 
activity is coordinate, supporting the view that the binding protein is involved 
in the rate-limiting step in the high-affinity leucine transport system (LIV-I). 
Since the biosynthesis of leucine is also repressed by external leucine, 
we examined the possibility that biosynthesis and transport of leucine shared 
common regulatory components. We examined the transport activity in mutant 
strains with derepressed leucine biosynthetic enzymes obtained from Dr. Um- 
barger. We found that the transport was normal and still regulated by leucine 
in the growth media. In addition a mutant with derepressed leucine transport 
activity, strain E03 12, showed normal regulation of the biosynthetic enzymes 
for leucine.” These data are summarized in TABLE 2.
TABLE 2 
THE SEPARATION OF BRANCHED-CHAIN MINO ACID TRANSPORT AND BIOSYNTHESIS 
Percent of Parent 
Strain 
Biosynthetic LIV Transport 
Phenotype Enzymes System 
c u 5  wild type 100 100 
CU5001 derepressed ZeuABCD, ilvB 700*t loot 
CU5002 derepressed ZeuABCD, 439*t 119t 
ilvB, ilvADE 
E0303 wildtype 100 100 
E0312 derepressed branched-chain 79t 200$ 
amino acid transport and 
binding proteins 
* Data are for theilvB gene product, acetohydroxy acid synthetase. Similar results were ob- 
t Data from Reference 19. 
$ Data from Reference 13. 
tained for the leuB gene product, isopropyl malate dehydrogenase. 
- 
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Transport Mutants 
Many of the mutant selection procedures are designed to use amino acid 
auxotrophs. The high-affinity transport systems that require binding proteins 
are greatly reduced in leucine auxotrophs since growth on leucine leads to 
their repression. 
In order to obtain mutants that were no longer repressed by the addition 
of leucine, we plated an auxotroph on D-leucine. D-Leucine is not transported 
efficiently enough to provide for a source of L-leucine via racemization in 
an auxotroph unless a derepression in transport occurs. When a wild-type 
E. coli K12 strain that has a lesion in leucine'biosynthesis is plated on 200 
mg/L D-leucine, D-leucine-utilizing mutants (DLU) were obtained. Most of 
these mutants had normal transport; however, about 3% of these mutants 
had greatly increased D- and L-leucine and isoleucine transport activity.", 
These mutants showed corresponding increases in the levels of the various 
binding proteins for leucine, isoleucine, and valine. 
One class of these mutants, represented by strain E03 12," shows derepressed 
levels of the high-affinity transport systems, and the addition of leucine to 
the growth media no longer represses the level of the high-affinity transport 
and the level of the three binding proteins. The kinetics of the high-affinity 
transport of leucine shows a two- to threefold increase in maximal capacity 
without significant changes in the Km value. This mutation has been partially 
mapped by genetic techniques and appears to be about 2% linked to the 
pyrD locus at minute 21 of the E. coli chromosome.22 
A second class of D-leucine utilizing mutants is represented by strain E0318. 
This mutant, like the previous mutant, also has a two- to threefold increase 
in leucine transport activity; however, the major increase in leucine transport 
results from an increased level of the leucine-specific system. The leucine- 
specific system makes up about 50% of the leucine uptake in this strain. 
The leucine-specific binding protein is also increased ~everalfold.'~ The LIV-I 
transport system appears unchanged in the E0318 strain and is still repressed 
by leucine. This regulatory mutation has been mapped and is 60 to 70% 
linked to the aroA locus at minute 20 on the E. coli chromosome." These 
regulatory mutants show increased transport activity as a result of the increased 
binding proteins, again indicating that the binding proteins are involved in 
the rate-limiting step in high-affinity branched-chain amino acid transport 
systems. 
Defective Transport Mutants 
The D-leucine-utilizing strains E03 1 1 and E03 18 are able to utilize D-leucine 
because of increased transport activity for D-leucine. Using these strains, we 
applied a penicillin selection in the presence of ~ l e u c i n e  to isolate transport 
mutants among the survivors. Several mutants were isolated that showed greatly 
decreased D- and L-leucine transport activity.I2 The transport defect in these 
mutants was shown to be in the high-affinity transport systems and the LIV-I1 
low-affinity membrane-bound system was relatively unaffected. We observed 
three types of transport mutants in these studies. One type proved to be 
defective in a large number of transport systems and was therefore considered 
to have a general membrane defect. The parental DLU strain E0311, which 
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had the high-affinity systems derepressed, was used to obtain a second type 
of mutant. This mutant, strain E0323, showed a loss in all the high-affinity 
systems, but appeared to have normal binding protein levels. Strain E0323 
apparently has a defect in a common component for the binding protein 
transport systems. A third type of transport mutant was derived from the 
parental DLU strain E03 18, which has high leucine-specific activity. This mutant 
strain, E0321, has lost only the specific leucine transport system. When we 
examined the shock fluid for leucine-specific binding activity, none was found. 
A protein fraction corresponding to the leucine-specific protein was eluted 
from DEAE columns at a slightly slower rate than authentic leucine-specific 
binding protein. This protein fraction could be detected in the eluate by its 
crossreactivity with antibody to the LIV-I binding protein. This strain, contain- 
ing a mutation in the structural gene of the leucine-specific binding protein, 
is being mapped to establish the position of the structural gene on the E. 
coli chromosome. 
Analog-Resistant Mutants 
The use of analogs of leucine such as azaleucine and trifluoroleucine have 
not been effective in obtaining mutants with defective binding proteins. The 
inability to obtain such mutants may have several causes. First, these analogs 
are not very toxic to wild-type strains. Second, they are ineffective for selection 
methods using leucine auxotrophs because the requirement for exogenous 
leucine in these strains prevents uptake of the analogs. In addition many 
strains are able to develop resistance to moderate levels of the analog by 
derepressing the leucine biosynthetic pathway. The DLU mutant strains with 
increased leucine uptake described above are much more sensitive to low 
levels of azaleucine or  trifluoroleucine. 
An examination of azaleucine transport activity in these strains shows 
that it can enter the cell by the LIV-I system and by the general aromatic 
amino acid transport system called aroP." Although the derepressed transport 
system can increase the sensitivity of a cell to azaleucine, extensive studies 
have indicated that a variety of cellular processes can alter the azaleucine 
toxicity." 
A large number of azaleucine-resistant mutants have been examined for 
leucine transport activity. Approximately 50% of the mutants have defective 
leucine transport. Some of these mutants have membrane defects and are 
thus pleiotropic transport mutants. The rest of the transport mutants have 
a specific defect in the high-affinity leucine transport system. An examination 
of several hundred has failed to yield a binding-protein negative mutant; there- 
fore, we conclude that the predominant transport mutant that derives from 
the analog resistance selection is defective in a common component of the 
high affinity systems other than the binding protein component. These mutants 
will be useful for characterizing the nonbinding protein components of the 
high-affinity leucine transport system. 
Valine-Resistant Mutants 
E. coli K12 is extremely sensitive to growth inhibition by low levels of 
L-valine since valine causes feedback inhibition of acetohydroxy acid synthetase, 
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a common enzyme in valine and isoleucine biosynthesis. Valine-induced growth 
inhibition is relieved by the addition of isoleucine to the medium. The most 
common class of valine-resistant mutants obtained is the regulatory mutant 
in the biosynthetic pathway for isoleucine and valine. Various mutations leading 
to the valine-resistant phenotype have been mapped at six different chromo- 
somal loci in E. cokW Guardiola and Iaccarino have used valine resistance 
in the presence of leucine and methionine to obtain several types of mutants.lK8 "
In addition to finding regulatory mutants for the ilv pathway they identified 
transport mutants. Some of these mutants have been genetically mapped, but 
the biochemical characterization is not sufficient at the present time to assign 
the defect to a specific branched-chain amino acid binding protein. 
Requirement of Binding Proteins in Chemotaxis 
Chemotaxis by E. coli has been the subject to extensive studies2'-" and 
will not be covered now except to indicate the relationship of certain binding 
proteins to chemotaxis. Although not all chemo receptors are shockable 
binding proteins, a number of the sugar-binding proteins appear to be absolutely 
required for chemotaxis toward the respective sugar. Chemotaxis of E. coli 
toward galactose,", *' ribose,'s and maltose*' requires the presence of the specific 
sugar-binding protein. There are additional components required for both trans- 
port and chemotaxis even though the binding protein serves as a common 
element. The relationship of the binding proteins to transport and chemotaxis 
can be diagrammed as follows: 
Transport Flagella 
components Other\ 1:: components 
Binding proteins 
There are transport-specific components not required for chemotaxis and 
chemotaxis-specific components not required for transport as illustrated in 
this diagram. These additional components have been identified by genetic 
 technique^.'^ Galactose transport mutants have been obtained that show normal 
chemotaxis for galactose and certain chemotactic mutants have normal trans- 
port. These latter types of mutants both have normal levels of galactose-binding 
protein. 
Role of Binding Proteins in Transport 
A variety of indirect evidence has accumulated to support a direct role 
of the binding protein in solute transport by the high-affinity shock-sensitive 
transport systems. These lines of evidence include: (a) osmotic shock treatment 
causing a parallel loss in transport activity and binding protein; (b) similarity 
of the kinetic constants; (c) parallel regulation of transport and binding protein 
activities; (d) localization of binding proteins to the periplasmic space; and 
(e) reversion of transport negative mutants that do not contain functional 
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binding proteins, which always results in a recovery of both transport and 
binding protein activities. 
Reconstitution studies to find direct evidence for a role of binding proteins 
have been generally discouraging, although genetic studies have provided direct 
evidence for a role of certain binding proteins. 
Mutants with Altered Binding Proteins 
Starting with strains that can utilize whistidine, Ames and Lever were 
able to isolate mutants with the histidine-binding protein (J) missing.”’ Rever- 
tants of these histidine transport mutants (induced by the frameshift mutagen 
ICR191 in a hisJ mutant that was itself induced with ICR191) were obtained 
that contained hisJ proteins with altered chemical and physical properties. 
The revertant strain was more temperature-sensitive for both growth and histi- 
dine transport activity than was the parental strain. The histidine-binding pro- 
tein isolated from the temperature-sensitive revertant was also more sensitive 
to heat treatment than normal histidine-binding protein. These data provide 
direct evidence for a role of the histidine-binding protein in the high-affinity 
histidine transport system. 
Direct evidence that the galactose-binding protein plays a role in p-methy1-D- 
galactoside transport was provided by obtaining mutants of E. coli that con- 
tained altered galactose-binding proteins that resulted in an altered chemotaxisZe 
and an altered transport of galacto~e.~’ The amino acid structure of the galac- 
tose-binding protein was found to be altered leading to a lower affinity for 
galactose which was reflected simultaneously in a higher Km value of transport 
and a higher threshold for the detection of positive chemotaxis specifically 
for galacto~e.’~ 
As indicated in an earlier section we have also isolated a mutant that 
appears to be in the structural gene of the leucine-specific binding protein. 
This mutation produces a CRM protein that results in the complete loss of 
leucine-specific transport activity. 
Recently Kustu and A m e P  obtained a histidine transport mutant from 
Salmonella typhimurium that had lost the high-affinity histidine transport, al- 
though it retained normal levels of the histidine-binding protein. This mutation 
proved to be in the structural gene of the histidine-binding protein, suggesting 
that a site on the binding protein other than the recognition site may serve 
for binding additional membrane components. 
on galactose transport have shown that mutants 
of the p-methyl-Dgalactoside transport system can all be placed in one of 
three classes using genetic complementation analysis.” The three genes have 
been called &A, mglB, and mglC and are genetically linked to the his loci 
of the E. coli chromosome. The mglB was determined to be the structural 
gene for the galactose-binding protein, and the products corresponding to 
mglA and mglC appear to be additional membrane-bound components of 
the galactose transport system. Robbins and Rotman“ found that the galactose- 
binding protein was required for active transport of galactose, although mg1B 
mutants could grow on high levels of galactose. They concluded that the 
binding protein was not involved in the translocation step in transport. 
FIGURE 4 presents a diagram of the possible role of the binding protein 
in galactose transport. Components A and C are believed to be membrane 
Extensive genetic studies”. 
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FIGURE 4. The role of the galac- 
tose-binding protein in galactose trans- 
port. OUT, outside; OM, outer mem- 
brane; IM, inner membrane; IN, inside 
of cell. 
components of the translocation process and the binding protein (B) creates 
an active transport system by increasing the affinity of the membrane-bound 
systems for galactose. Robbins and Rotman" suggest that the affinity of the 
system may be as much as 1000 times greater in the presence of the binding 
protein, although the capacity of the system is not altered by the presence 
of the binding protein. 
Silhavy et al." have prepared an extensive review of the evidence for 
the role of the galactose-binding protein. In agreement with Robbins and 
R ~ t m a n , ~ "  they do not believe that the binding protein for galactose is involved 
in the translocation step. They review the evidence for two sugar binding 
sites on the galactose-binding protein. These authors suggest that one site is 
the recognition site for galactose and that the other is a glycoprotein recog- 
nition site. Their model predicts that either or both of components A and 
C in the membrane may be a glycoprotein, and they have experiments under 
way to test this possibility. 
The results from our laboratory on the role of the leucine-binding protein 
in transport are not in disagreement with those found for galactose. At the 
present time, most of our data suggest that LIV-I and LIV-I1 are parallel 
systems and not connected by a series of steps, although some mutants appear 
to be defective in both LIV-I and LIV-I1 transport systems, which suggests 
they may share a common component. 
Conclusions 
The recent studies have clearly established two types of active transport 
systems. One type is membrane-bound and can be observed in membrane 
vesicles and the other type is osmotic-shock-sensitive and requires binding 
proteins to produce active transport. It appears that the membrane-bound 
systems derive cellular energy from an energy-rich membrane state which 
can be formed from respiration or ATP-hydrolysis, while the binding protein 
systems are more directly coupled to phosphate bond energy derived from 
glycolysis or oxidative phosphorylation. 
The following conclusions concerning the role of the binding proteins 
are offered: 
1. The binding proteins are present in relatively large amounts (-1O-' 
or 
2. They do not appear to be involved in solute translocation steps, although 
they contain a second binding site that could interact with membrane 
components. 
M) and appear to reside in the periplasmic space. 
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3. The binding proteins appear to  increase the affinity of the transport 
system for the solute by interacting with a membrane component. This may 
result from the possibility that the solute-binding protein complex is the actual 
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Discussion 
DR. TOSTESON: I wonder whether binding proteins function so poorly 
as transporters because their affinities for  the transported substances are too 
372 Annals New York Academy of Sciences 
high and the rate coefficient for release is too low? To that end it would 
be interesting to know whether there is any evidence either in bacterial systems 
or in vesicles that binding proteins can actually go all the way through the 
bilayer . 
DR. OXENDER: The binding proteins don’t appear to have measurable af- 
finities; also we’ve sent protein to Thompson at Virginia, and he has at- 
tempted to see whether they would have any affinity for lipid bilayers, and 
his experimental results were negative. We’ve also taken iiposomes and loaded 
them with radioactive leucine and then added the binding protein to see if 
binding proteins will stimulate the efflux of leucine; again the results were 
negative. 
